Yahoo Web Search

Search results

    • Kymera Therapeutics soars as Sanofi expands phase 2 trials

      Investing.com via Yahoo Singapore Finance· 18 hours ago

      Investing.com - Kymera Therapeutics Inc , (NASDAQ:KYMR) a clinical-stage biopharmaceutical firm specializing in the development of novel small molecule medicines using targeted protein degradation ...